Johnson & Johnson price

$261,15$-0,29 (−0,11 %)
Last updated on --.

About Johnson & Johnson

Johnson & Johnson on holdingyhtiö, joka harjoittaa terveydenhuollon alan tuotteiden tutkimusta, kehitystä, valmistusta ja myyntiä. Se toimii innovatiivisen lääketieteen ja medtech-segmenttien kautta. Innovatiivisen lääketieteen segmentti keskittyy immunologiaan, infektiosairauksiin, neurotieteeseen, onkologiaan, sydän- ja verenkierto- ja aineenvaihduntaan sekä keuhkoverenpainetautiin. MedTech-segmentti sisältää tuotevalikoiman, jota käytetään interventioratkaisuissa, ortopediassa, kirurgiassa ja näköalalla. Yrityksen perustivat Robert Wood Johnson I, James Wood Johnson ja Edward Mead Johnson Sr. vuonna 1887, ja sen pääkonttori sijaitsee New Brunswickissa, New Jerseyssä.

Osaketunnus
JNJ
Yritys
Johnson & Johnson
Teollisuus
Terveydenhuolto
Kategoria
US
Osakeanti / osakeyhdistäminen
12
Lanseerauspäivä
2.1.1962
Listattu pörssi
NYSE

Taloustiedot

Q2 FY2026 tulos
Raporttikausi: 30.3.2026 – 28.6.2026

Yhteenveto: JNJ reported Revenue of 25.31B (+6,60 %), beating expectations; EPS of 2,90 (+4,69 %), beating expectations.

Tulot (USD)Lyö25,31 mrd.+6,59 %25,06 mrd.+9,66 %247,68 milj.+0,98 %
EPS (USD)Lyö2,90+4,69 %2,84+5,97 %0,06+2,11 %
Taloudelliset arviot
● Todellinen● Arvio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
2,292,122,102,142,27
+18,65 %+90,99 %+48,93 %−52,87 %−0,88 %
● EPS● Vuosi vuodelta
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
193,39 mrd.192,82 mrd.199,21 mrd.200,89 mrd.201,06 mrd.
114,92 mrd.113,54 mrd.117,67 mrd.119,71 mrd.116,09 mrd.
59,42 %58,88 %59,06 %59,58 %57,73 %
● Varat● Velat● Suhde
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
3,88 mrd.9,17 mrd.7,31 mrd.2,51 mrd.4,71 mrd.
−31,16 %+14,71 %+4,66 %−39,77 %+21,48 %
● CFO● Vuosi vuodelta

Osakkeenomistajat

Osakkeenomistajat
BLACKROCK, INC.8,69 %
VANGUARD CAPITAL MANAGEMENT LLC6,44 %
STATE STREET CORP5,47 %
VANGUARD PORTFOLIO MANAGEMENT LLC2,63 %
GEODE CAPITAL MANAGEMENT, LLC2,42 %
Muut74,33 %
Laitokset
% Omistettu74,49 %+1,87 %
Omistetut osakkeet1,82 mrd.+42,12 milj.
Instituutiot4 807+52
% OmistettuHinta
Nimi% OmistettuVaihda
BLACKROCK, INC.8,69 %−-1,29 milj.
VANGUARD CAPITAL MANAGEMENT LLC6,44 %+621,00 t.
STATE STREET CORP5,47 %+299,74 t.
VANGUARD PORTFOLIO MANAGEMENT LLC2,63 %+856,38 t.
GEODE CAPITAL MANAGEMENT, LLC2,42 %−-78,45 t.

Osingot

Osingot
Viimeinen osingon irtoamispäivä: 25.8.2026 Käteisosinko: 1,34 USD osakkeelta
Dividend yield TTM
2,01 %
Maksusuhde LFY
46,60 %
Taajuus
Neljännesvuosittain
20222023202420252026
4,454,704,915,143,98
+2,52 %+3,13 %+3,17 %+2,48 %+1,93 %
Dividend amount (USD)Osinkotuotto
Osakejaot
Lanseerauspäivä: 2.1.1962
PäivämääräSuhde
13.6.20011 → 2
12.6.19961 → 2
10.6.19921 → 2
11.5.19891 → 2
19.5.19811 → 3
18.5.19701 → 3
19.6.19671 → 3
Trade on the go with the OKX app

Johnson & Johnson performance

$261,15
Johnson & Johnson price today

Johnson & Johnson price today is $261,15, marking a −0,11 % over the past 24 hours. On OKX, today’s Johnson & Johnson trading volume reached --, worth over --.

$261,15
Johnson & Johnson in USD

The current Johnson & Johnson to USD conversion rate is $261,15 per Johnson & Johnson.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.

More to explore

FAQ

XJNJ is trading at $261,15, −0,11 % over the last 24 hours. Track live moves on the price chart at the top of this page.

The XJNJ stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XJNJ is currently trading at $261,15, −0,11 % over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XJNJ price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Terveydenhuolto sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XJNJ's P/E ratio is currently 30,29 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XJNJ; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XJNJ's historical range and other companies in the Terveydenhuolto sector.

Johnson & Johnson's market cap is currently 630,04 mrd. USD. Market cap is calculated as stock price × total shares outstanding.